While we wait for something to happen, it looks like the MM's have decided (for now) that we will stay in the 0.83-0.85 trading range. We might see a few attempts to break the lower end of that range, but we might also see an attempt to move it up. CDEL have been support and frankly I have no idea if they are buying to cover clients or to have shares to keep the upward momentum down. One thing is for sure, they have gobbled up a lot of shares, even at these low levels of volume.
I am still of the belief that we could see the MIA any day now and that this could spur a seldom seen PR from NWBO. As for the other rumors, I have not myself been able to find any support for them. I have a few friends who are desperately calling their friends to find any little bit of knowledge they can, and I will gladly share if/when I get some info that is not considered inside info.
I was pointed to NWBO by someone who had a long time working relationship with NWBO as a third party service provider. They put their working relationship on hold when the trial ended. That person was very certain to let me know that NWBO was a 'legacy' project for LP. How to use that information is up to each and every one. I take it to mean that she will be involved through approval and maybe even through commercialization process.
I will remain patient and watch the next few months play out. I am looking forward to the LL webinar on Monday, but only from a science perspective and with no expectations that anything she will reveal will have much influence on the short term SP. I do believe that she is now completely free to discuss a multitude of things we all want to know about, UNLESS she is in the process of writing another article for JAMA that has her embargoed about secondary endpoints and the combination trial.
I really don't know if we get any more info from NWBO, outside of a potential MIA cert acceptance prior to the definitive proxy or the ASM, but here's hoping.
Have a wonderful day.
Bullish
